BioPharma Credit (LON:BPCR - Get Free Report)'s stock price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 0.87 ($0.01) and traded as low as GBX 0.86 ($0.01). BioPharma Credit shares last traded at GBX 0.86 ($0.01), with a volume of 319,248 shares changing hands.
BioPharma Credit Price Performance
The stock has a fifty day moving average price of GBX 0.86 and a 200-day moving average price of GBX 0.87. The company has a market cap of £954.52 million, a PE ratio of 9.14 and a beta of 0.22.
BioPharma Credit Cuts Dividend
The company also recently disclosed a dividend, which will be paid on Wednesday, May 7th. Investors of record on Thursday, April 3rd will be given a dividend of $0.02 per share. The ex-dividend date is Thursday, April 3rd. This represents a yield of 1.99%. BioPharma Credit's payout ratio is 7,957.15%.
About BioPharma Credit
(
Get Free Report)
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
See Also
Before you consider BioPharma Credit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioPharma Credit wasn't on the list.
While BioPharma Credit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
